Reviving Extinct Species: The Controversial Vision of Colossal Biosciences

Rebecca Stone, Science Editor
5 Min Read
⏱️ 4 min read

Colossal Biosciences, a biotechnology firm headquartered in Dallas, is at the forefront of a profound scientific endeavour: the resurrection of extinct species, including the woolly mammoth and the dodo. With a valuation of $10.2 billion, bolstered by high-profile investments, the company has generated significant attention and debate over its controversial methods and the ethical implications of “de-extinction”. Critics argue that the pursuit could undermine conservation efforts, while proponents see it as a moral obligation in the face of an ongoing extinction crisis.

The Quest for De-Extinction

At the heart of Colossal’s ambitious project is advanced genetic technology aimed at reversing the effects of extinction. The company first made headlines last year when it announced the birth of three dire wolf pups, a species that vanished over 10,000 years ago. Colossal’s CEO, Ben Lamm, envisions a future where not only the dire wolf but also the woolly mammoth will roam the Earth once more, with the first mammoth expected to be born by 2028, followed by the dodo.

Lamm, who embraces the comparisons to the fictional world of *Jurassic Park*, believes that these efforts can rekindle interest in conservation. “We have a moral obligation to respond to the extinction crisis,” he stated, highlighting the rapid degradation of biodiversity caused by human activity.

Innovative Genetic Techniques

Colossal’s laboratory, a 55,000 square foot facility in Dallas, is equipped with cutting-edge technology designed to isolate and edit ancient DNA. Using CRISPR gene-editing tools, scientists aim to modify the genomes of living relatives to reintroduce traits of their extinct ancestors. For instance, the dire wolf hybrids have undergone specific genetic alterations to enhance their size and cold resistance, drawing on the DNA of modern grey wolves.

Innovative Genetic Techniques

However, the complexities of such projects are immense. The challenge of resurrecting the thylacine, for instance, involves over a million gene edits, as the closest living relative—a small marsupial—bears little resemblance to the extinct carnivorous marsupial.

The Ethical and Ecological Dilemma

Despite the excitement surrounding Colossal’s innovations, the scientific community is divided. Some experts question the feasibility and ethical implications of de-extinction. Vincent Lynch, a specialist in evolutionary biology, argues that calling genetically modified grey wolves “dire wolves” is misleading. “You can’t simply apply a mutation to a related species and claim that you’ve resurrected the extinct one,” he asserted, emphasising the philosophical complexities surrounding species definition.

Moreover, critics warn that focusing on de-extinction could detract from vital conservation efforts aimed at protecting endangered species. The notion of reviving extinct animals may lead to complacency, reducing the urgency to safeguard existing ecosystems and their inhabitants.

The Future of Conservation

While Colossal’s ambitious projects capture the public’s imagination, the company acknowledges the necessity of addressing contemporary conservation challenges. Their technology could play a significant role in increasing genetic diversity among endangered species, developing vaccines against diseases that threaten populations, and even enhancing resilience against invasive species.

The Future of Conservation

Beth Shapiro, Colossal’s chief scientist, insists that the company’s mission extends beyond de-extinction. “We interpret ‘de-extinction’ as a practical gateway to develop next-generation conservation tools,” she explained. This broader application could prove crucial in combating the imminent threat of extinction facing numerous species today.

Why it Matters

The work being undertaken by Colossal Biosciences represents a pivotal moment in the intersection of technology and conservation. As the planet faces an unprecedented extinction crisis, the implications of their research could redefine our approach to biodiversity preservation. While the allure of resurrecting iconic species like the woolly mammoth captivates public interest, the true measure of success will lie in how effectively these advancements can be employed to protect and sustain the rich tapestry of life that remains. Balancing innovation with ethical responsibility will be essential for ensuring that technological progress does not come at the expense of the very ecosystems we strive to restore.

Share This Article
Rebecca Stone is a science editor with a background in molecular biology and a passion for science communication. After completing a PhD at Imperial College London, she pivoted to journalism and has spent 11 years making complex scientific research accessible to general audiences. She covers everything from space exploration to medical breakthroughs and climate science.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 The Update Desk. All rights reserved.
Terms of Service Privacy Policy